Invention Grant
US07708994B2 Therapy of autoimmune disease in a patient with an inadequate response to a TNF-α inhibitor
有权
在对TNF-α抑制剂反应不足的患者中自身免疫性疾病的治疗
- Patent Title: Therapy of autoimmune disease in a patient with an inadequate response to a TNF-α inhibitor
- Patent Title (中): 在对TNF-α抑制剂反应不足的患者中自身免疫性疾病的治疗
-
Application No.: US11439906Application Date: 2006-05-24
-
Publication No.: US07708994B2Publication Date: 2010-05-04
- Inventor: Mark C. Benyunes
- Applicant: Mark C. Benyunes
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agent Wendy M. Lee
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/00
Abstract:
The present application describes therapy with antagonists which bind to B cell surface markers, such as CD20. In particular, the application describes the use of such antagonists to treat autoimmune disease in a mammal who experiences an inadequate response to a TNFα-inhibitor.
Public/Granted literature
- US20060240008A1 Therapy of autoimmune disease in a patient with an inadequate response to a TNF-alpha inhibitor Public/Granted day:2006-10-26
Information query
